The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has received a U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the Zika Virus RNA Qualitative Real-Time RT-PCR test (Zika RT-PCR test).
A pair of molecular signals controls skin and hair color in mice and humans — and could be targeted by new drugs to treat skin pigment disorders like vitiligo, according to a report by scientists at NYU Langone Medical Center.
Eating Chocolate Each Day Could Reduce Heart Disease And Diabetes Risk
The U.S. Food and Drug Administration today approved the first generic version of Crestor (rosuvastatin calcium) tablets for the following uses:
Changes in key genes clearly define four previously unknown conditions within the umbrella diagnosis of schizophrenia, according to a study led by researchers from NYU Langone Medical Center published online April 28 in EBioMedicine, a Lancet journal.
The American Urological Association (AUA), together with the Society for Urologic Oncology (SUO), today released a new clinical practice guideline on non-muscle invasive bladder cancer (NMIBC).
Specialized proteins can protect monkeys against the virus for months:
The finding provides further evidence that antibodies—specialized proteins that the body produces to fight infections—could one day be used as a method to prevent people from becoming infected with HIV.
Scientists are teaching computers to figure out why people accept or decline invitations to participate in clinical trials.
In the first gene therapy of its kind in humans, a clinical trial has begun at Nationwide Children’s Hospital to evaluate a new investigative treatment for victims of a rare neurodegenerative disorder, Batten disease CLN6.